These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 33182840)
61. The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target. Gambardella V; Castillo J; Tarazona N; Gimeno-Valiente F; Martínez-Ciarpaglini C; Cabeza-Segura M; Roselló S; Roda D; Huerta M; Cervantes A; Fleitas T Cancer Treat Rev; 2020 Jun; 86():102015. PubMed ID: 32248000 [TBL] [Abstract][Full Text] [Related]
62. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer. Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316 [TBL] [Abstract][Full Text] [Related]
63. Chemokines in tumor progression and metastasis. Sarvaiya PJ; Guo D; Ulasov I; Gabikian P; Lesniak MS Oncotarget; 2013 Dec; 4(12):2171-85. PubMed ID: 24259307 [TBL] [Abstract][Full Text] [Related]
64. Altered levels of plasma chemokines in breast cancer and their association with clinical and pathological characteristics. Narita D; Seclaman E; Anghel A; Ilina R; Cireap N; Negru S; Sirbu IO; Ursoniu S; Marian C Neoplasma; 2016; 63(1):141-9. PubMed ID: 26639244 [TBL] [Abstract][Full Text] [Related]
65. The important role played by chemokines influence the clinical outcome of Helicobacter pylori infection. Jafarzadeh A; Nemati M; Jafarzadeh S Life Sci; 2019 Aug; 231():116688. PubMed ID: 31348950 [TBL] [Abstract][Full Text] [Related]
66. Chemokine Receptor Signaling and the Hallmarks of Cancer. Lacalle RA; Blanco R; Carmona-Rodríguez L; Martín-Leal A; Mira E; Mañes S Int Rev Cell Mol Biol; 2017; 331():181-244. PubMed ID: 28325212 [TBL] [Abstract][Full Text] [Related]
68. The role of Tenascin-C and Twist1 in gastric cancer: cancer progression and prognosis. Qi W; Yang Z; Li H; Cui Y; Xuan Y APMIS; 2019 Feb; 127(2):64-71. PubMed ID: 30698309 [TBL] [Abstract][Full Text] [Related]
69. AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients. Liu JY; Jiang L; Liu JJ; He T; Cui YH; Qian F; Yu PW Sci Rep; 2018 Aug; 8(1):11955. PubMed ID: 30097586 [TBL] [Abstract][Full Text] [Related]
70. Matrix Metalloproteinases and Their Tissue Inhibitors in Comparison to Other Inflammatory Proteins in Gastric Cancer (GC). Łukaszewicz-Zając M; Szmitkowski M; Litman-Zawadzka A; Mroczko B Cancer Invest; 2016 Aug; 34(7):305-12. PubMed ID: 27414231 [TBL] [Abstract][Full Text] [Related]
71. Signaling-chemokine axis network in brain as a sanctuary site for metastasis. Azizidoost S; Asnafi AA; Saki N J Cell Physiol; 2019 Apr; 234(4):3376-3382. PubMed ID: 30187487 [TBL] [Abstract][Full Text] [Related]
72. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer. Yu ZH; Wang YM; Jiang YZ; Ma SJ; Zhong Q; Wan YY; Wang XW Pathol Res Pract; 2019 Oct; 215(10):152553. PubMed ID: 31362888 [TBL] [Abstract][Full Text] [Related]
73. The Role of Chemokines in Thyroid Carcinoma. Yapa S; Mulla O; Green V; England J; Greenman J Thyroid; 2017 Nov; 27(11):1347-1359. PubMed ID: 28891394 [TBL] [Abstract][Full Text] [Related]
74. Chemokines and Chemokine Receptors in the Development of NAFLD. Roh YS; Seki E Adv Exp Med Biol; 2018; 1061():45-53. PubMed ID: 29956205 [TBL] [Abstract][Full Text] [Related]
75. Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact. Braoudaki M; Ahmad MS; Mustafov D; Seriah S; Siddiqui MN; Siddiqui SS Semin Cancer Biol; 2022 Nov; 86(Pt 2):436-449. PubMed ID: 35700938 [TBL] [Abstract][Full Text] [Related]
76. Diagnosis and Management of Gastric Intestinal Metaplasia: Current Status and Future Directions. Huang RJ; Choi AY; Truong CD; Yeh MM; Hwang JH Gut Liver; 2019 Nov; 13(6):596-603. PubMed ID: 31394893 [TBL] [Abstract][Full Text] [Related]
77. Long non-coding RNA linc00261 suppresses gastric cancer progression via promoting Slug degradation. Yu Y; Li L; Zheng Z; Chen S; Chen E; Hu Y J Cell Mol Med; 2017 May; 21(5):955-967. PubMed ID: 27878953 [TBL] [Abstract][Full Text] [Related]
78. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis. Wu W; Juan WC; Liang CR; Yeoh KG; So J; Chung MC Proteomics Clin Appl; 2012 Apr; 6(3-4):152-62. PubMed ID: 22532451 [TBL] [Abstract][Full Text] [Related]
79. Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer. Aldinucci D; Casagrande N Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772686 [TBL] [Abstract][Full Text] [Related]